Clinicopathological features and prognosis assessment of extranodal follicular dendritic cell sarcoma
AIM: To establish a model for prognosis assessment of extranodal follicular dendritic cell (FDC) sarcoma.METHODS: Nine lesions were examined by routine and molecular approaches.Clinicopathological factors from the new cases and 97 reported cases were analyzed for their prognostic values.RESULTS: The...
Saved in:
| Published in | World journal of gastroenterology : WJG Vol. 16; no. 20; pp. 2504 - 2519 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | English |
| Published |
United States
Department of Pathology,Cancer Institute and Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China%Departments of Pathology,the First Affiliated Hospital,Inner Mongolia Medical College,Huhehot 010059,Inner Mongolia Autonomous Region,China%Department of Pathology,Renmin Hospital,In-ner Mongolia Medical College,Huhehot 010020,Inner Mongolia Autonomous Region,China%Department of Radiology,Cancer Institute and Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China
28.05.2010
Baishideng |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | AIM: To establish a model for prognosis assessment of extranodal follicular dendritic cell (FDC) sarcoma.METHODS: Nine lesions were examined by routine and molecular approaches.Clinicopathological factors from the new cases and 97 reported cases were analyzed for their prognostic values.RESULTS: The current lesions were found in f ive male and four female patients,located mainly in the head and neck area and averaging 7.2 cm in size.Six patients had recurrence or metastasis and three remained free of diseas... |
|---|---|
| AbstractList | AIM: To establish a model for prognosis assessment of extranodal follicular dendritic cell (FDC) sarcoma.
METHODS: Nine lesions were examined by routine and molecular approaches. Clinicopathological factors from the new cases and 97 reported cases were analyzed for their prognostic values.
RESULTS: The current lesions were found in five male and four female patients, located mainly in the head and neck area and averaging 7.2 cm in size. Six patients had recurrence or metastasis and three remained free of disease. The 106 patients (male/female ratio, 1.1:1) were aged from 9 to 82 years (median, 44 years). The tumor sizes ranged from 1.5 to 21 cm (mean, 7.4 cm). Abdominal/pelvic region was affected most frequently (43%). Surgical resection was performed in 100 patients, followed by radiation and/or chemotherapy in 35 of them. Follow-up data were available in 91 cases, covering a period of 3-324 mo (mean, 27 mo; median, 19 mo). Of the informative cases, 38 (42%) had recurrence or metastasis, and 12 (13%) died of the disease. These tumors were classified histologically into low- and high-grade lesions. A size ≥ 5 cm (
P
= 0.003), high-grade histology (
P
= 0.046) and a mitotic count ≥ 5/10 HPF (
P
= 0.013) were associated with tumor recurrence. The lesions were defined as low-, intermediate- and high-risk tumors, and their recurrence rates were 16%, 46% and 73%, and their mortality rates 0%, 4% and 45%, respectively.
CONCLUSION: Extranodal FDC tumors behave like soft tissue sarcomas. Their clinical outcomes are variable and can be evaluated according to their sizes and grades. R73; AIM: To establish a model for prognosis assessment of extranodal follicular dendritic cell (FDC) sarcoma. METHODS: Nine lesions were examined by routine and molecular approaches. Clinicopathological factors from the new cases and 97 reported cases were ana-lyzed for their prognostic values. RESULTS: The current lesions were found in five male and four female patients, located mainly in the head and neck area and averaging 7.2 cm in size. Six patients had recurrence or metastasis and three remained free of disease. The 106 patients (male/female ratio, 1.1:1) were aged from 9 to 82 years (median, 44 years). The tumor sizes ranged from 1.5 to 21 cm (mean, 7.4 cm). Abdominal/pelvic region was affected most frequently (43%). Surgical resection was performed in 100 pa-tients, followed by radiation and/or chemotherapy in 35 of them. Follow-up data were available in 91 cases, covering a period of 3-324 mo (mean, 27 mo; median, 19 mo). Of the informative cases, 38 (42%) had recur-rence or metastasis, and 12 (13%) died of the disease. These tumors were classified histologically into low- and high-grade lesions. A size ≥ 5 cm (P = 0.003), high-grade histology (P = 0.046) and a mitotic count ≥ 5/10 HPF (P = 0.013) were associated with tumor recur-rence. The lesions were defined as low-, intermediate- and high-risk tumors, and their recurrence rates were 16%, 46% and 73%, and their mortality rates 0%, 4% and 45%, respectively. CONCLUSION: Extranodal FDC tumors behave like soft tissue sarcomas. Their clinical outcomes are variable and can be evaluated according to their sizes and grades. To establish a model for prognosis assessment of extranodal follicular dendritic cell (FDC) sarcoma.AIMTo establish a model for prognosis assessment of extranodal follicular dendritic cell (FDC) sarcoma.Nine lesions were examined by routine and molecular approaches. Clinicopathological factors from the new cases and 97 reported cases were analyzed for their prognostic values.METHODSNine lesions were examined by routine and molecular approaches. Clinicopathological factors from the new cases and 97 reported cases were analyzed for their prognostic values.The current lesions were found in five male and four female patients, located mainly in the head and neck area and averaging 7.2 cm in size. Six patients had recurrence or metastasis and three remained free of disease. The 106 patients (male/female ratio, 1.1:1) were aged from 9 to 82 years (median, 44 years). The tumor sizes ranged from 1.5 to 21 cm (mean, 7.4 cm). Abdominal/pelvic region was affected most frequently (43%). Surgical resection was performed in 100 patients, followed by radiation and/or chemotherapy in 35 of them. Follow-up data were available in 91 cases, covering a period of 3-324 mo (mean, 27 mo; median, 19 mo). Of the informative cases, 38 (42%) had recurrence or metastasis, and 12 (13%) died of the disease. These tumors were classified histologically into low- and high-grade lesions. A size > or = 5 cm (P = 0.003), high-grade histology (P = 0.046) and a mitotic count > or = 5/10 HPF (P = 0.013) were associated with tumor recurrence. The lesions were defined as low-, intermediate- and high-risk tumors, and their recurrence rates were 16%, 46% and 73%, and their mortality rates 0%, 4% and 45%, respectively.RESULTSThe current lesions were found in five male and four female patients, located mainly in the head and neck area and averaging 7.2 cm in size. Six patients had recurrence or metastasis and three remained free of disease. The 106 patients (male/female ratio, 1.1:1) were aged from 9 to 82 years (median, 44 years). The tumor sizes ranged from 1.5 to 21 cm (mean, 7.4 cm). Abdominal/pelvic region was affected most frequently (43%). Surgical resection was performed in 100 patients, followed by radiation and/or chemotherapy in 35 of them. Follow-up data were available in 91 cases, covering a period of 3-324 mo (mean, 27 mo; median, 19 mo). Of the informative cases, 38 (42%) had recurrence or metastasis, and 12 (13%) died of the disease. These tumors were classified histologically into low- and high-grade lesions. A size > or = 5 cm (P = 0.003), high-grade histology (P = 0.046) and a mitotic count > or = 5/10 HPF (P = 0.013) were associated with tumor recurrence. The lesions were defined as low-, intermediate- and high-risk tumors, and their recurrence rates were 16%, 46% and 73%, and their mortality rates 0%, 4% and 45%, respectively.Extranodal FDC tumors behave like soft tissue sarcomas. Their clinical outcomes are variable and can be evaluated according to their sizes and grades.CONCLUSIONExtranodal FDC tumors behave like soft tissue sarcomas. Their clinical outcomes are variable and can be evaluated according to their sizes and grades. To establish a model for prognosis assessment of extranodal follicular dendritic cell (FDC) sarcoma. Nine lesions were examined by routine and molecular approaches. Clinicopathological factors from the new cases and 97 reported cases were analyzed for their prognostic values. The current lesions were found in five male and four female patients, located mainly in the head and neck area and averaging 7.2 cm in size. Six patients had recurrence or metastasis and three remained free of disease. The 106 patients (male/female ratio, 1.1:1) were aged from 9 to 82 years (median, 44 years). The tumor sizes ranged from 1.5 to 21 cm (mean, 7.4 cm). Abdominal/pelvic region was affected most frequently (43%). Surgical resection was performed in 100 patients, followed by radiation and/or chemotherapy in 35 of them. Follow-up data were available in 91 cases, covering a period of 3-324 mo (mean, 27 mo; median, 19 mo). Of the informative cases, 38 (42%) had recurrence or metastasis, and 12 (13%) died of the disease. These tumors were classified histologically into low- and high-grade lesions. A size > or = 5 cm (P = 0.003), high-grade histology (P = 0.046) and a mitotic count > or = 5/10 HPF (P = 0.013) were associated with tumor recurrence. The lesions were defined as low-, intermediate- and high-risk tumors, and their recurrence rates were 16%, 46% and 73%, and their mortality rates 0%, 4% and 45%, respectively. Extranodal FDC tumors behave like soft tissue sarcomas. Their clinical outcomes are variable and can be evaluated according to their sizes and grades. AIM: To establish a model for prognosis assessment of extranodal follicular dendritic cell (FDC) sarcoma.METHODS: Nine lesions were examined by routine and molecular approaches.Clinicopathological factors from the new cases and 97 reported cases were analyzed for their prognostic values.RESULTS: The current lesions were found in f ive male and four female patients,located mainly in the head and neck area and averaging 7.2 cm in size.Six patients had recurrence or metastasis and three remained free of diseas... |
| Author | Li, Lan |
| AuthorAffiliation | Department of Pathology,Cancer Institute and Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China%Departments of Pathology,the First Affiliated Hospital,Inner Mongolia Medical College,Huhehot 010059,Inner Mongolia Autonomous Region,China%Department of Pathology,Renmin Hospital,In-ner Mongolia Medical College,Huhehot 010020,Inner Mongolia Autonomous Region,China%Department of Radiology,Cancer Institute and Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China |
| AuthorAffiliation_xml | – name: Department of Pathology,Cancer Institute and Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China%Departments of Pathology,the First Affiliated Hospital,Inner Mongolia Medical College,Huhehot 010059,Inner Mongolia Autonomous Region,China%Department of Pathology,Renmin Hospital,In-ner Mongolia Medical College,Huhehot 010020,Inner Mongolia Autonomous Region,China%Department of Radiology,Cancer Institute and Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China |
| Author_xml | – sequence: 1 givenname: Lan surname: Li fullname: Li, Lan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20503450$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UU2PFCEUJGaNO7t692T6YOKpxwc0A30xMRO_kk286JkADT2MDMxC9-7676Uzs0Y9eHohr6peFXWFLmKKFqGXGNaUd-Lt_X5c3-HN2hNYEwbdE7QiBPctER1coBUG4G1PCb9EV6XsAQiljDxDlwQY0I7BCtlt8NGbdFTTLoU0eqNC46ya5mxLo-LQHHMaYyq-vkqxpRxsnJrkGvswZRXTsOBTCN7MQeVmsHHIfvKmMTaEpqhs0kE9R0-dCsW-OM9r9P3jh2_bz-3N109ftu9vWsNwP7W9cUZZPrCBsq43QlvQmuIBU2YE3milwQiujXbCQe96ohTlSrth2LjOaUav0buT7nHWBzuYajWrII_ZH1T-KZPy8u9N9Ds5pjtJBOdYQBV4fRK4V9GpOMp9mnOslmX9agIYCACICntzvpPT7WzLJA--LIFVtGkuklOKgQuBK_LVn45-W3lsoAI2J4DJqZRsnTR-UpNPi0EfJAa5VL3cl7VqWauWS9WVCP8QH7X_QzmnM7sUx1tf82llfjgfbCUBJoxxTOgvKiy9mA |
| CitedBy_id | crossref_primary_10_1007_s12328_024_01956_5 crossref_primary_10_1097_MD_0000000000003377 crossref_primary_10_1080_00015458_2019_1689646 crossref_primary_10_14309_crj_0000000000000008 crossref_primary_10_1186_s12957_023_03115_5 crossref_primary_10_1016_j_inat_2019_100557 crossref_primary_10_1177_014556131008900702 crossref_primary_10_1002_dc_24584 crossref_primary_10_1186_s12876_019_1008_y crossref_primary_10_1097_PAS_0000000000001205 crossref_primary_10_1186_s12957_023_03213_4 crossref_primary_10_1002_hon_2275 crossref_primary_10_1097_MD_0000000000034289 crossref_primary_10_4132_KoreanJPathol_2012_46_3_306 crossref_primary_10_1016_j_anndiagpath_2020_151595 crossref_primary_10_1177_030089161309900231 crossref_primary_10_12998_wjcc_v7_i1_116 crossref_primary_10_1136_bcr_2017_221505 crossref_primary_10_4103_jcrt_jcrt_1534_22 crossref_primary_10_3389_fimmu_2021_653319 crossref_primary_10_12998_wjcc_v7_i20_3194 crossref_primary_10_1111_cyt_13047 crossref_primary_10_1186_1752_1947_8_113 crossref_primary_10_1136_bcr_2021_244175 crossref_primary_10_12998_wjcc_v7_i6_785 crossref_primary_10_5858_arpa_2021_0517_OA crossref_primary_10_1200_JCO_2011_37_1906 crossref_primary_10_1016_j_oraloncology_2024_106690 crossref_primary_10_1097_MD_0000000000007261 crossref_primary_10_1016_j_critrevonc_2013_05_006 crossref_primary_10_1186_s13000_022_01246_z crossref_primary_10_1186_s13000_019_0779_3 crossref_primary_10_3892_ol_2014_2681 crossref_primary_10_1111_his_14169 crossref_primary_10_1136_bcr_2018_224301 crossref_primary_10_5106_jjshns_30_247 crossref_primary_10_1007_s12029_018_0178_0 crossref_primary_10_1097_MD_0000000000002404 crossref_primary_10_1177_17588359251318863 crossref_primary_10_1016_j_dld_2020_04_014 crossref_primary_10_3892_ol_2014_2726 crossref_primary_10_3919_jjsa_84_1227 crossref_primary_10_1177_10668969221133352 crossref_primary_10_1177_20363613231172077 crossref_primary_10_1186_s13104_016_2189_x crossref_primary_10_1007_s12105_019_01015_3 crossref_primary_10_1016_j_canrad_2013_10_010 crossref_primary_10_1016_j_prp_2014_09_015 crossref_primary_10_2217_fon_15_315 crossref_primary_10_1055_s_0042_1742319 crossref_primary_10_3892_ol_2021_12443 crossref_primary_10_3892_ol_2013_1224 crossref_primary_10_5106_jjshns_23_375 crossref_primary_10_5631_jibirin_109_563 crossref_primary_10_5858_arpa_2019_0703_RA crossref_primary_10_3919_jjsa_75_3147 crossref_primary_10_4103_IJPM_IJPM_461_20 crossref_primary_10_1016_j_oraloncology_2019_104515 crossref_primary_10_1002_dc_25371 crossref_primary_10_1177_03000605221142401 crossref_primary_10_3748_wjg_v25_i45_6693 crossref_primary_10_1177_039463201102400231 crossref_primary_10_1080_16078454_2023_2260975 crossref_primary_10_1136_jcp_2025_210074 crossref_primary_10_1177_0300060520920433 crossref_primary_10_1186_1746_1596_6_94 crossref_primary_10_1186_s12894_019_0517_x crossref_primary_10_3390_cancers6042275 crossref_primary_10_1007_s12105_014_0537_5 crossref_primary_10_4103_IJPM_IJPM_663_20 crossref_primary_10_4132_KoreanJPathol_2014_48_2_140 crossref_primary_10_1200_JCO_2010_32_7932 crossref_primary_10_1111_his_12998 crossref_primary_10_1177_1066896916651494 crossref_primary_10_1007_s12105_024_01659_w crossref_primary_10_1177_107327481402100405 crossref_primary_10_3960_jslrt_53_179 crossref_primary_10_5981_jjhnc_44_376 crossref_primary_10_1097_RTI_0b013e318220309f crossref_primary_10_1097_PAI_0000000000001241 crossref_primary_10_1179_1607845415Y_0000000008 crossref_primary_10_1007_s12105_020_01152_0 |
| ClassificationCodes | R73 |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. 2010 Baishideng. All rights reserved. 2010 |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. – notice: 2010 Baishideng. All rights reserved. 2010 |
| DBID | 2RA 92L CQIGP W91 ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 2B. 4A8 92I 93N PSX TCJ 5PM |
| DOI | 10.3748/wjg.v16.i20.2504 |
| DatabaseName | 维普_期刊 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | Clinicopathological features and prognosis assessment of extranodal follicular dendritic cell sarcoma |
| EISSN | 2219-2840 |
| EndPage | 2519 |
| ExternalDocumentID | PMC2877180 wjg201020008 20503450 10_3748_wjg_v16_i20_2504 1001255712 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: National Natural Science Founda-tion of China(30171052; 30572125; 30772508) funderid: National Natural Science Founda-tion of China(30171052; 30572125; 30772508) |
| GroupedDBID | --- 123 29R 2B. 2C~ 2RA 2WC 36B 53G 5VR 8WL 92F 92I 92L 93N 93R AAKDD ACGFO AENEX AFUIB ALMA_UNASSIGNED_HOLDINGS CCEZO CDYEO CHBEP CIEJG CQIGP CS3 CW9 DIK DU5 E3Z EBS EJD EMB F5P FA0 FRP GX1 HYE M~E OK1 P2P RNS RPM SV3 TCJ TGQ TR2 W91 WFFXF XSB ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 4A8 PSX 5PM |
| ID | FETCH-LOGICAL-c519t-9cfcae7d5d3549c8be0bb31d135c816bab0c87bcbf8f09f92aa37abfdd6f4fb53 |
| ISSN | 1007-9327 2219-2840 |
| IngestDate | Thu Aug 21 18:08:21 EDT 2025 Thu May 29 03:55:22 EDT 2025 Fri Jul 11 02:16:10 EDT 2025 Wed Oct 16 00:47:29 EDT 2024 Tue Jul 01 03:21:49 EDT 2025 Thu Apr 24 22:59:49 EDT 2025 Fri Nov 25 07:22:36 EST 2022 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 20 |
| Keywords | Histologic grade Immunohisto-chemistry Prognosis assessment Mutation detection Extranodal follicular dendritic cell sarcoma In situ hybridization |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c519t-9cfcae7d5d3549c8be0bb31d135c816bab0c87bcbf8f09f92aa37abfdd6f4fb53 |
| Notes | Histologic grade Immunohistochemistry Prognosis assessment Extranodal follicular dendritic cell sarcoma; Prognosis assessment; Histologic grade; Immunohistochemistry; In situ hybridization; Mutation detection Mutation detection Extranodal follicular dendritic cell sarcoma R730.4 14-1219/R In situ hybridization ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Correspondence to: Qin Su, Professor, Department of Pathology, Cancer Institute and Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Panjiayuan Nanli 17, Beijing 100021, China. q.su@wjgnet.com Telephone: +86-10-87787508 Fax: +86-10-67713359 Author contributions: Su Q designed the research and performed pathologic re-examination; Li L, Qiu T, Guo L and Guo ZJ performed the research; Shi YH, Yang HY and Zhang X participated in pathologic re-examination; Zhao XM participated in re-evaluation of the radiological data; Su Q and Li L evaluated data and prepared the manuscript. |
| OpenAccessLink | https://www.wjgnet.com/1007-9327/full/v16/i20/2504.htm |
| PMID | 20503450 |
| PQID | 733107881 |
| PQPubID | 23479 |
| PageCount | 16 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2877180 wanfang_journals_wjg201020008 proquest_miscellaneous_733107881 pubmed_primary_20503450 crossref_citationtrail_10_3748_wjg_v16_i20_2504 crossref_primary_10_3748_wjg_v16_i20_2504 chongqing_backfile_1001255712 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2010-05-28 |
| PublicationDateYYYYMMDD | 2010-05-28 |
| PublicationDate_xml | – month: 05 year: 2010 text: 2010-05-28 day: 28 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | World journal of gastroenterology : WJG |
| PublicationTitleAlternate | World Journal of Gastroenterology |
| PublicationTitle_FL | WORLD JOURNAL OF GASTROENTEROLOGY |
| PublicationYear | 2010 |
| Publisher | Department of Pathology,Cancer Institute and Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China%Departments of Pathology,the First Affiliated Hospital,Inner Mongolia Medical College,Huhehot 010059,Inner Mongolia Autonomous Region,China%Department of Pathology,Renmin Hospital,In-ner Mongolia Medical College,Huhehot 010020,Inner Mongolia Autonomous Region,China%Department of Radiology,Cancer Institute and Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China Baishideng |
| Publisher_xml | – name: Department of Pathology,Cancer Institute and Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China%Departments of Pathology,the First Affiliated Hospital,Inner Mongolia Medical College,Huhehot 010059,Inner Mongolia Autonomous Region,China%Department of Pathology,Renmin Hospital,In-ner Mongolia Medical College,Huhehot 010020,Inner Mongolia Autonomous Region,China%Department of Radiology,Cancer Institute and Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China – name: Baishideng |
| SSID | ssj0023352 |
| Score | 2.2996595 |
| Snippet | AIM: To establish a model for prognosis assessment of extranodal follicular dendritic cell (FDC) sarcoma.METHODS: Nine lesions were examined by routine and... To establish a model for prognosis assessment of extranodal follicular dendritic cell (FDC) sarcoma. Nine lesions were examined by routine and molecular... To establish a model for prognosis assessment of extranodal follicular dendritic cell (FDC) sarcoma.AIMTo establish a model for prognosis assessment of... R73; AIM: To establish a model for prognosis assessment of extranodal follicular dendritic cell (FDC) sarcoma. METHODS: Nine lesions were examined by routine... AIM: To establish a model for prognosis assessment of extranodal follicular dendritic cell (FDC) sarcoma. METHODS: Nine lesions were examined by routine and... |
| SourceID | pubmedcentral wanfang proquest pubmed crossref chongqing |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2504 |
| SubjectTerms | Adolescent Adult Aged Aged, 80 and over Child Dendritic Cell Sarcoma, Follicular - diagnosis Dendritic Cell Sarcoma, Follicular - metabolism Dendritic Cell Sarcoma, Follicular - pathology Dendritic Cell Sarcoma, Follicular - therapy Disease-Free Survival Female Humans Male Middle Aged Neoplasm Recurrence, Local - pathology Original Prognosis Retrospective Studies Review Literature as Topic Sarcoma - pathology Treatment Outcome Tumor Suppressor Protein p53 - genetics Tumor Suppressor Protein p53 - metabolism Young Adult |
| Title | Clinicopathological features and prognosis assessment of extranodal follicular dendritic cell sarcoma |
| URI | http://lib.cqvip.com/qk/84123X/201020/1001255712.html https://www.ncbi.nlm.nih.gov/pubmed/20503450 https://www.proquest.com/docview/733107881 https://d.wanfangdata.com.cn/periodical/wjg201020008 https://pubmed.ncbi.nlm.nih.gov/PMC2877180 |
| Volume | 16 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgCIkXBOIrQJEfeEFTunw5dh4RAk0T8LSJvUX-7ApVAm22SfvruUtcN-0GYrxEbeqcXN_Pl7N99ztC3hbMMG2VjHOZ6hg8YhMLZmVsudaYiZnbPnj8y9fy8KQ4OmWnmyp9fXZJp6b66sa8kv_RKtwDvWKW7C00G4TCDfgM-oUraBiu_6TjgdSzxarCwYY521N1rjwDQIuBdHP4Fhg40T0EiwzvqNb02YuLxXwIRgUTZPrKB_u4nb-_gjnQerPt3dch9GbENjGTq27ZIq_nciBzwh2Gb0ehYNdnn3zdjHcXhoPxbGwQcSsTfDy-ZTHLETKyZGz_2FBMeNcwI8kNjObl99n0Ii2n8yyZrptuc2DvvJtCxCCsVVBGDRJgXV_WIKFGCXfJvQwWCPl6n8YvtTGTrD_n9r0fDqhRwsFuH5BU46xtZr_AVdh2Tq6tOK4Hzt6_lI2TzWzkkxw_Ig_9YoK-H5DxmNyxzRNib0AFXaOCAipoQAXdoIK2jm5QQTeooAEVFFFBPSqekpNPH48_HMa-mEaswUnv4ko7LS03zOSsqLRQNlEqT02aMy3SUkmVaMGVVk64pHJVJmXOpXLGlK5wiuXPyF7TNvYFodalTmpRWpuaItO8Ypm0msmESy6YEBGZhBEFZ0z_QIoxJMcGZ5rxNIvIwXqUa-2Z6LEgyqL-k5Yj8i488XNgYflLW7pWXA2mEodGNrY9X9VYnjTB8gkReT7oMQjLkBapYElE-JaGQwNkYd_-pZmf9WzsmeDg38GTE4-F2s_CFXYN5xRmw4mXt_gLr8iDzVx8Tfa65bmdgO_bqTc9zH8DsOy35A |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinicopathological+features+and+prognosis+assessment+of+extranodal+follicular+dendritic+cell+sarcoma&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Li%2C+Lan&rft.date=2010-05-28&rft.issn=1007-9327&rft.volume=16&rft.issue=20&rft.spage=2504&rft_id=info:doi/10.3748%2Fwjg.v16.i20.2504&rft.externalDBID=n%2Fa&rft.externalDocID=10_3748_wjg_v16_i20_2504 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F84123X%2F84123X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fwjg%2Fwjg.jpg |